IPAD-DB ID | S00813 |
Name | Methyl caffeate |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 0 H 1 0 O 4 |
Molecular Weight | 194.18 g/mol |
IUPAC Name | methyl(E)-3-(3, 4-dihydroxyphenyl)prop-2-enoate |
InChI | InChI=1S/C10H10O4/c1-14-10(13)5-3-7-2-4-8(11)9(12)6-7/h2-6, 11-12H, 1H3/b5-3+ |
InChIKey | OCNYGKNIVPVPPX-HWKANZROSA-N |
Canonical SMILES | COC(=O)C=CC1=CC(=C(C=C1)O)O |
PubChem CID | 689075 |
DrugBank Accession Number | - |
CAS Registry Number | 3843-74-1 |
Molecular Weight(Computed by SwissADME) | 194.18 |
Hac(Computed by SwissADME) | 14 |
Volume(Computed by ADMETlab 2.0) | 194.938 |
Density(Computed by ADMETlab 2.0) | 0.995 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 8 |
Flexibility(Computed by ADMETlab 2.0) | 0.375 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -1.27 |
LogD(Computed by ADMETlab 2.0) | 1.979 |
logP(Computed by ADMETlab 2.0) | 1.957 |
TPSA(Computed by SwissADME) | 66.76 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.43 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |